Vaccine-preventable diseases

All Items

• How reliable are Australian Childhood Immunisation Register coverage estimates for Indigenous children? An assessment of data quality and coverage

  Claudia Rank, Robert I Menzies

  283-287

• Current developments in varicella-zoster virus disease prevention. A report on the varicella-zoster virus workshop convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 16-17 November 2006

  Anita E Heywood, Kristine K Macartney, C Raina MacIntyre, Peter B McIntyre

  303-310

• Vaccine Preventable Diseases and Vaccination Coverage in Australia, 2003 to 2005

  Julia Brotherton, Han Wang, Andrea Schaffer, Helen Quinn, Robert Quinn, Brynley Hull, Glenda Lawrence, James Wood, Nicolas Wood, Alexander Rosewell, Anthony Newall, Raina MacIntyre, Kristine Macartney, Heather F Gidding, Peter McIntyre, Robert Booy, National Centre for Immunisation Research and Surveillance

  ix, S1-S152

• Pertussis epidemiology in Australia over the decade 1995–2005 – trends by region and age group

  Helen E Quinn, Peter B McIntyre

  205-215

• Reduction in invasive meningococcal disease in Queensland: A success for immunisation

  Vicki G Slinko, Amy Sweeny

  227-232

• Composition of the Australian Influenza Vaccine for the 2007 season

  Australian Influenza Vaccine Committee

  260

• Nosocomial and community transmission of measles virus genotype D8 imported by a returning traveller from Nepal

  Kathryn M Weston, Dominic E Dwyer, Mala Ratnamohan, Ken McPhie, Sau-wan Chan, James M Branley, Lisa J Allchin, Krishna P Hort

  358-365

• Composition of Australian influenza vaccine for the 2005 season

  Australian Influenza Vaccine Committee

  61

• An Outbreak of measles in Adelaide

  James E Fielding

  80-82

• The Acceptance of three simultaneous vaccine injections recommended at 12 months of age

  Jeffrey N Hanna, Ruth C Bullen, Debora E Andrews

  493-496

• Top End rural and remote Indigenous women: an Australian population group vulnerable to rubella

  Jennifer M Hunt, Judith Lumley

  499-503

• The Cost of seasonal respiratory illnesses in Australian children: the dominance of patient and family costs and implications for vaccine use

  Stephen Lambert, Kerry-Ann O'Grady, Susan Gabriel, Robert Carter, Terry Nolan

  509-516

• Vaccine Preventable Diseases and Vaccination Coverage in Australia, 2001 to 2002

  Julia Brotherton, Peter McIntyre, Michele Puech, Han Wang, Heather Gidding, Brynley Hull, Glenda Lawrence, Raina MacIntyre, Nicholas Wood, Donna Armstrong

  ix, S1-S116

• Festschrift for Professor Margaret Burgess AO

  Julia M L Brotherton

  349-355

• Antiviral prophylaxis in the management of an influenza outbreak in an aged care facility

  Kym A Bush, Jeremy McAnulty, Ken McPhie, Roderick Reynolds, Melanie Boomer, Lisa M Clarkson, Julianne Quaine, Dominic E Dwyer

  396-400

• What do we know about 7vPCV coverage in Aboriginal and Torres Strait Islander children?

  Brynley P Hull, Peter B McIntyre

  238-243

• Age-related risk of adverse events following yellow fever vaccination in Australia

  Glenda L Lawrence, Margaret A Burgess, Robert B Kass

  244-248

• Impact of Haemophilus influenzae type b (Hib) vaccination on Hib meningitis in children in Far North Queensland, 1989 to 2003

  Jeffrey N Hanna

  255-257

• Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002 [Supplementary issue]

  Robert Menzies, Peter McIntyre, Frank Beard, National Centre for Immunisation Research and Surveillance

  S1-S45

• Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002

  Robert Menzies, Peter McIntyre, Frank Beard, National Centre for Immunisation Research and Surveillance

  127-158

• National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases

  National Centre for Immunisation Research and Surveillance

  92-95

• Interruption of rubella virus transmission in Australia may require vaccination of adult males: evidence from a Victorian sero-survey

  Heath Kelly, Theo Karapanagiotidis

  69-73

• A resurgence of congenital rubella in Australia?

  Margaret A Burgess, Jill M Forrest, Tim Donovan

  533-535

• Rubella in Australia: can we explain two recent cases of congenital rubella syndrome?

  Heather Gidding, Margaret Young, Robyn Pugh, Margaret Burgess

  537-540

• Estimating immunisation coverage: is the 'third dose assumption' still valid?

  Brynley P Hull, Glenda L Lawrence, C Raina MacIntyre, Peter B McIntyre

  357-361

• Invasive pneumococcal disease among children in Victoria

  Min Liu, Ross Andrews, Joanne Stylianopoulos, Catherine Ferreira, Geoff Hogg, Nyree Pyper

  362-366

• Surveillance of viral pathogens in Australia - varicella-zoster virus

  Paul Roche, Charlie Blumer, Jenean Spencer

  576-580

• Using the Australian Childhood Immunisation Register to track the transition from whole-cell to acellular pertussis vaccines

  Siranda Torvaldsen, Brynley P Hull, Peter B McIntyre

  581-583

• Infection control and public health aspects of a case of pertussis infection in a maternity health care worker

  Bradley J McCall, Martyn Tilse, Beth Burt, Peter Watt, Mary Barnett, Joseph G McCormack

  584-586

• Observational methods in epidemiologic assessment of vaccine effectiveness

  Siranda Torvaldsen, Peter B McIntyre

  451-457

• A measles outbreak among young adults in Victoria, February 2001

  Natasha Davidson, Ross Andrews, Michaela Riddell, Jenny Leydon, Pauline Lynch

  273-278

• Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000

  Peter McIntyre, Heather Gidding, Robin Gilmour, Glenda Lawrence, Brynley Hull, Peter Horby, Han Wang, Ross Andrews, Margaret Burgess, National Centre for Immunisation Research and Surveillance

  xi, 1-111

• Annual report of the National Influenza Surveillance Scheme, 2000

  Paul Roche, Jenean Spencer, Angela Merianos, Alan Hampson

  107-112

• An outbreak of serogroup C meningococcal disease associated with a secondary school

  Priscilla Robinson, Kath Taylor, John Carnie, Graham F Tallis, Graham Roche, Julia Griffiths, David Tribe, Angelo Zaia, Hua Li, Geoff Hogg

  121-125

• Measles immunity among young adults in Victoria

  Heath Kelly, Michaela Riddell, Stephen B Lambert, Jennie A Leydon, Mike G Catton

  129-132

• Measles immunity in young Australian adults

  Heather Gidding, Gwendolyn L Gilbert

  133-136

• Epidemiology of malaria in Victoria 1999-2000: East Timor emerges as a new source of disease

  Susan A Skull, Graham Tallis

  149-151

• Locally-acquired Plasmodium falciparum malaria on Darnley Island in the Torres Strait

  Dave Harley, Gaynor Garstone, Brian L Montgomery, Scott A Ritchie

  151-153

• A case of Kunjin virus encephalitis in a traveller returning from the Northern Territory

  Patrick Charles, Jennie A Laydon, Kerry-Ann O'Grady, Bryan R Speed

  155-156

• Varicella vaccine in post-exposure prophylaxis

  Mark J Ferson

  13-15

• Outbreak report: measles cluster in south-eastern Sydney with transmission in a general practice waiting room

  Infectious Diseases Team and Director, South Eastern Sydney Public Health Unit

  19

• The Outbreak that had to happen: Bordatella pertussis in North-West Western Australia in 1999

  Suzanne P Cordova, Marisa T Gilles, Mary Y Beers

  375-379

• Measles elimination - a case definition to enhanced surveillance

  Dave N Durrheim, Rick Spear

  329-331

• Guidelines for the control of measles outbreaks in Australia

  Robert Hall, Measles Elimination Advisory Committee (MEAC)

  331

• Letters to the editor: Rubella; and, Guidelines for the control of measles outbreaks in Australia

  Adrian K Thomas, Christine Selvey

  299

• Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998 (summary report)

  Peter McIntyre, Janaki Amin, Heather Gidding, Brynley Hull, Siranda Torvaldsen, Andrew Tucker, Fiona Turnbull, Margaret Burgess

  276-277

• Notifications of vaccine preventable diseases in Australia, quarterly report (January-March 2000)

  Heather F Gidding, Janaki Amin, Peter B McIntyre

  239-241

• Young adult measles vaccination

  Margaret Campbell

  241

• Measles in health care facilities: some salutary lessons

  Jeffrey Hanna, Ann Richards, Dallas Young, Susan Hills, Jan Humphreys

  211-212

• Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998

  Janaki Amin, Heather Gidding, Brynley Hull, Siranda Torvaldsen, Andrew Tucker, Fiona Turnbull, Margaret Burgess, National Centre for Immunisation Research and Surveillance

  vii, 1-83

• Factors influencing vaccination uptake (Workshop Report: Current Australian research on the behavioural, social and demographic factors influencing immunisation, Royal Alexandra Hospital for Children, Sydney, March 1998)

  Jill M Forrest, Margaret A Burgess, Peter B McIntyre

  5-53

• Adverse Events Following Immunisation associated with the 1998 Australian Measles Control Campaign

  Rennie M D'Souza, Sue Campbell-Lloyd, David Isaacs, Michael Gold, Margaret Burgess, Fiona Turnbull, Eddie O'Brien

  27-33

• An Outbreak of measles in a rural Queensland town in 1997: an opportunity to assess vaccine effectiveness

  Heather F Gidding, Susan Hills, Linda Selvey, Leslee A Roberts, Susan Johnston

  240-245

• The Epidemiology of rubella and congenital rubella in Australia, 1992 to 1997

  Eleanor M Sullivan, Margaret A Burgess, Jill M Forrest

  209-214

• Current issues in immunisation: Measles-Mumps-Rubella immunisation, autism and inflammatory bowel disease: update

  Janaki Amin, Melanie Wong

  222

• Rubella infection in pregnancy

  Christopher Coulter, Robyn Wood, Jenny Robson

  93-96

• Victorian measles outbreak

  No authors listed

  75

• Vaccine-associated paralytic poliomyelitis

  Margaret A Burgess, Peter B McIntyre

  80-81

• A National Measles Surveillance Strategy

  Tim Heath, Margaret Burgess, Peter McIntyre, Michael Catton

  41-50

• Implementing a system of enhanced surveillance for measles in Victoria

  Enhanced Measles Surveillance Working Party

  51-54